Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study
| Image |  |
|---|---|
| Description | scientific article published on 31 October 2018 |
| Author/s |
author: Martin Hutchings Harm van Tinteren Pieternella J Lugtenburg Josée M. Zijlstra |
| Publication date | October 31, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |